These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 6846366
1. Procedures for handling antineoplastic injections in comprehensive cancer centers. LeRoy ML, Roberts MJ, Theisen JA. Am J Hosp Pharm; 1983 Apr; 40(4):601-3. PubMed ID: 6846366 [Abstract] [Full Text] [Related]
2. Veterans Administration medical center policies and procedures for handling injectable antineoplastic drugs. Moody DG. Am J Hosp Pharm; 1984 May; 41(5):916-9. PubMed ID: 6731452 [Abstract] [Full Text] [Related]
5. The handling of antineoplastic drugs in a major cancer center. Hoffman DM. Hosp Pharm; 1980 Jun; 15(6):302-4. PubMed ID: 10247269 [Abstract] [Full Text] [Related]
7. Risk of handling injectable antineoplastic agents. Anderson RW, Puckett WH, Dana WJ, Nguyen TV, Theiss JC, Matney TS. Am J Hosp Pharm; 1982 Nov; 39(11):1881-7. PubMed ID: 6756133 [Abstract] [Full Text] [Related]
8. Antineoplastic admixture service in a tertiary-care hospital. Friedman TS, Triboletti M, Sandusky RM, Katz S. Am J Hosp Pharm; 1984 Oct; 41(10):2037-44. PubMed ID: 6496492 [Abstract] [Full Text] [Related]
9. Comprehensive program for handling hazardous drugs. Arrington DM, McDiarmid MA. Am J Hosp Pharm; 1993 Jun; 50(6):1170-4. PubMed ID: 8517456 [Abstract] [Full Text] [Related]
10. Developing guidelines for working with antineoplastic drugs. Harrison BR. Am J Hosp Pharm; 1981 Nov; 38(11):1686-93. PubMed ID: 7304620 [Abstract] [Full Text] [Related]
11. Recommendations for the safe handling of injectable antineoplastic drug products. Zimmerman PF, Larsen RK, Barkley EW, Gallelli JF. Am J Hosp Pharm; 1981 Nov; 38(11):1693-5. PubMed ID: 7304621 [Abstract] [Full Text] [Related]
13. Implementing guidelines for managing extravasation of antineoplastics. Hirsh JD, Conlon PF. Am J Hosp Pharm; 1983 Sep; 40(9):1516-9. PubMed ID: 6624754 [Abstract] [Full Text] [Related]
14. Cost of implementing Veterans Administration directives for handling antineoplastic agents. Murphy CP, Goldspiel BR, Koeller J. Am J Hosp Pharm; 1987 Apr; 44(4):788-91. PubMed ID: 3578312 [Abstract] [Full Text] [Related]
15. Managing employee apprehension toward handling cytotoxic drugs. Moore TD, Hale KM, Cortese LM, Fillmore AD, Jozefczyk KG, Scala SM, Wellman GS. Am J Hosp Pharm; 1985 Apr; 42(4):826-31. PubMed ID: 4014233 [Abstract] [Full Text] [Related]
16. Veterans Administration procedures for handling cytotoxic agents. Harrison BR, Moody DG. Am J Hosp Pharm; 1984 Dec; 41(12):2590. PubMed ID: 6517079 [No Abstract] [Full Text] [Related]
17. National survey of pharmacy-coordinated investigational drug services. Young LM, Haakenson CM, Weber JH, Tosch TJ. Am J Hosp Pharm; 1984 Sep; 41(9):1792-6. PubMed ID: 6496514 [Abstract] [Full Text] [Related]
18. Exposure of hospital workers to airborne antineoplastic agents. deWerk Neal A, Wadden RA, Chiou WL. Am J Hosp Pharm; 1983 Apr; 40(4):597-601. PubMed ID: 6846365 [Abstract] [Full Text] [Related]
19. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. Valanis BG, Vollmer WM, Labuhn KT, Glass AG. Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461 [Abstract] [Full Text] [Related]